Health Trials

Relapsed or Refractory Lymphomas

1

Review clinical trials related to Relapsed or Refractory Lymphomas. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

The goal of this clinical trial is to evaluate the safety and tolerability of escalating doses of LP-284 and to determine the maximum tolerated dose (MTD) and the recommended Phase 2 dose (RP2D) in patients with relapsed or refractory (R/R) lymphomas and solid tumors. The secondary objectives are to characterize the pharmacokinetics (PK) of LP-284 and to assess clinical activity of LP-284.

Participants needed: 110
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Lantern Pharma Inc.Updated: May 4, 2026Locations: 1
Eligibility criteria

Male or female aged ≥ 18 years on the day of signing informed consent. [+10]

History or suspicion of central nervous system (CNS) lymphoma or meningeal invol... [+23]

Read more